I'll retrieve comprehensive information about the glycan with GlyTouCan accession number 'G01543ZX' using the glycan_detail tool.Based on the comprehensive data retrieved for glycan G01543ZX, here's a detailed analysis of its chemical properties, biological associations, classifications, and cross-references:

## Chemical Properties

**Basic Structure Information:**
- **Molecular Mass:** 2,733.97 Da (permethylated mass: 3,392.71 Da)
- **Monosaccharide Count:** 14 sugar units
- **Composition:** HexNAc(5)Hex(6)dHex(1)NeuAc(2)
  - 5 N-Acetylhexosamines (N-Acetylglucosamine)
  - 6 Hexoses (3 Mannose + 3 Galactose)
  - 1 6-Deoxy-hexose (Fucose)
  - 2 N-Acetyl-neuraminic acid (sialic acid)

**Structural Representations:**
- **WURCS:** Available (complex notation for precise structure)
- **GlycoCT:** Available (detailed structural format)
- **Byonic notation:** HexNAc(5)Hex(6)dHex(1)NeuAc(2)

## Biological Classifications

**Primary Classification:**
- **Type:** N-linked glycan
- **Subtype:** Complex, Core-fucosylated, Triantennary

**Structural Motifs:**
- Type 2 LN (N-acetyllactosamine)
- 3-Sialyl-LN (type 2)

## Species Distribution

Found in multiple species with experimental evidence:
- **Homo sapiens (Human)** - Primary species with extensive evidence
- **Cricetulus griseus (Chinese hamster)** - Secondary evidence

## Protein Associations

**Major Glycoproteins:**
1. **Hepatocyte Growth Factor (HGF, P14210-1)**
   - Multiple N-glycosylation sites: Asn294, Asn402, Asn566, Asn653
   - Evidence: PubMed 8407880, GlyConnect

2. **Coagulation Factor VIII (F8, P00451-1)**
   - Evidence: PubMed 8969451, GlyConnect

3. **Alpha-N-acetylgalactosaminidase (NAGA, P17050-1)**
   - Evidence: PubMed 10704524, GlyConnect

## Enzymatic Biosynthesis Pathway

The glycan is synthesized through a complex enzymatic pathway involving multiple transferases:

**Core Formation:**
- DPAGT1: Initial N-acetylglucosamine attachment
- ALG13/ALG14: Core extension
- ALG1, ALG2: Mannose additions

**Complex Formation:**
- MGAT1: First branching GlcNAc addition
- MGAT2: Second branching point
- MGAT4A/B/C: Additional branching for triantennary structure

**Terminal Modifications:**
- B4GALT1/2/3: Galactose additions
- FUT8: Core fucosylation
- Sialyltransferases: Terminal sialic acid additions

## Tissue Expression

Primarily found in:
- **Ovary tissue** (UBERON:0000992)
- Associated with multiple glycoproteins in reproductive tissues

## Database Cross-References

**Primary Databases:**
- **GlyTouCan:** G01543ZX (canonical glycan registry)
- **GlyConnect:** 3590 (glycoproteomics data)
- **GlyCosmos:** Integrated glycome database
- **PubChem Substance:** 491870996

**Specialized Resources:**
- **SandBox:** Enzyme and pathway information
- **GNOme:** Ontology and nomenclature

## Research Publications

Three key publications document this glycan:
1. **Ohta et al. (2000)** - Glycobiology: N-acetylgalactosaminidase glycosylation
2. **Hara et al. (1993)** - J. Biochemistry: Hepatocyte growth factor glycosylation
3. **Kumar et al. (1996)** - Biotechnol. Appl. Biochem.: Factor VIII glycosylation

## Structural Relationships

**Subsumption Network:**
- Has 25 ancestor structures (simpler glycans)
- Has 3 descendant structures (more complex variants)
- Related to G62765SF, G10228OD, G16150CJ as fully determined forms

## Research Significance

This glycan represents a complex triantennary N-linked structure with dual sialylation and core fucosylation, making it important for:
- **Protein stability and function** (especially blood coagulation factors)
- **Cell recognition and signaling** (hepatocyte growth factor)
- **Glycan-protein interactions** in mammalian systems
- **Biomarker development** for glycoprotein characterization

The comprehensive enzymatic pathway information makes it valuable for understanding N-glycan biosynthesis and potential therapeutic targeting of glycosylation processes.